DICE Therapeutics, Inc.
DICEDelisted Aug 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645569
DICE Therapeutics, Inc. was delisted on Aug 9, 2023; its insiders filed their last Form 4 on Aug 9, 2023; 160 institutions reported holding it in 13F filings for Q2 2023, worth $2.12B in total; Fairfax Financial was the only superinvestor holding it.
Holders of 5% or more of DICE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of DICE Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of DICE Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on DICE Therapeutics, Inc., newest first.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 28, 2021 | Northpond Ventures, LP | 13DOld format | – | New | – | SEC |
| Sep 27, 2021 | Sands Capital Life Sciences Pulse Fund II, L.P. | 13DOld format | – | New | – | SEC |
| Sep 27, 2021 | Ra Capital Management, L.P. | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell DICE Therapeutics, Inc. shares.
No Form 144 notices for DICE Therapeutics, Inc. are on file.